Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States

What it means

This order aims to reduce U.S. dependence on foreign manufacturers for essential medicines and medical supplies. It directs federal agencies to purchase domestically produced medicines and medical countermeasures when possible, while establishing a framework to identify supply chain vulnerabilities.

Expected impact

• Increased domestic manufacturing of essential medicines and medical supplies
• Potential cost increases for government procurement of medical products
• Greater supply chain security for critical medical items during emergencies
• Possible trade tensions with countries affected by new procurement restrictions
• Accelerated FDA approval processes for domestic manufacturers of essential medicines